<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">2983306R</journal-id>
<journal-id journal-id-type="pubmed-jr-id">3565</journal-id>
<journal-id journal-id-type="nlm-ta">Epilepsia</journal-id>
<journal-id journal-id-type="iso-abbrev">Epilepsia</journal-id>
<journal-title-group>
<journal-title>Epilepsia</journal-title>
</journal-title-group>
<issn pub-type="ppub">0013-9580</issn>
<issn pub-type="epub">1528-1167</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27554343</article-id>
<article-id pub-id-type="pmc">5547884</article-id>
<article-id pub-id-type="doi">10.1111/epi.13506</article-id>
<article-id pub-id-type="manuscript">NIHMS882361</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>The spectrum of epilepsy and electroencephalographic abnormalities
due to <italic>SHANK3</italic> loss of function mutations</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Holder</surname>
<given-names>J. Lloyd</given-names>
<suffix>Jr.</suffix>
</name>
<degrees>MD, PhD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="author-notes" rid="FN1">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quach</surname>
<given-names>Michael M.</given-names>
</name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Baylor College of Medicine and Texas Children’s
Hospital</aff>
<author-notes>
<corresp id="FN1"><label>2</label>Corresponding author. J. Lloyd Holder, Jr., MD, PhD, Assistant
Professor of Pediatrics, Division of Neurology and Developmental Neuroscience,
1250 Moursund St., Suite 1350, Houston, Texas 77030,
<email>holder@bcm.edu</email>, Telephone: 832-822-1750, Fax:
832-825-1717</corresp>
<fn fn-type="COI-statement" id="FN3">
<p id="P32">None of the authors has any conflict of interest to disclose.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>6</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>10</month>
<year>2017</year>
</pub-date>
<volume>57</volume>
<issue>10</issue>
<fpage>1651</fpage>
<lpage>1659</lpage>
<!--elocation-id from pubmed: 10.1111/epi.13506-->
<abstract>
<title>Summary</title>
<sec id="S1">
<title>Objective</title>
<p id="P1">The coincidence of autism with epilepsy is 27% in those
individuals with intellectual disability<sup><xref ref-type="bibr" rid="R1">1</xref></sup>. Individuals with loss of function mutations in
<italic>SHANK3</italic> have intellectual disability, autism and
variably, epilepsy<sup><xref ref-type="bibr" rid="R2">2</xref>–<xref ref-type="bibr" rid="R5">5</xref></sup>. The spectrum of seizure
semiologies and electroencephalographic (EEG) abnormalities has never been
investigated in detail. With the recent report that <italic>SHANK3</italic>
mutations are present in approximately two percent of individuals with
moderate to severe intellectual disabilities and one percent of individuals
with autism, determining the spectrum of seizure semiologies and
electrographic abnormalities will be critical for medical practitioners to
appropriately counsel the families of patients with <italic>SHANK3</italic>
mutations.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">A retrospective chart review was performed of all individuals treated
at the Blue Bird Circle Clinic for Child Neurology who have been identified
as having either a chromosome 22q13 microdeletion encompassing
<italic>SHANK3</italic> or a loss of function mutation in
<italic>SHANK3</italic> identified through whole exome sequencing.</p>
<p id="P3">For each subject, the presence or absence of seizures, seizure
semiology, frequency, age of onset and efficacy of therapy were determined.
Electroencephalograms were reviewed by a board certified neurophysiologist.
Neuroimaging was reviewed by both a board certified pediatric
neuroradiologist and child neurologist.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P4">There is a wide spectrum of seizure semiologies, frequencies and
severity in individuals with <italic>SHANK3</italic> mutations. There are no
specific electroencephalographic abnormalities found in our cohort, and EEG
abnormalities were present in individuals diagnosed with epilepsy and those
without history of a clinical seizure.</p>
</sec>
<sec id="S4">
<title>Significance</title>
<p id="P5">All individuals with a mutation in <italic>SHANK3</italic> should be
evaluated for epilepsy due to the high prevalence of seizures in this
population. The most common semiology is atypical absence seizure which can
be challenging to identify due to comorbid intellectual disability in
individuals with <italic>SHANK3</italic> mutations; however, no consistent
seizure semiology, neuroimaging findings or electroencephalogram findings
were present in the majority of individuals with <italic>SHANK3</italic>
mutations.</p>
</sec>
</abstract>
<kwd-group>
<kwd>
<italic>SHANK3</italic>
</kwd>
<kwd>Phelan-McDermid Syndrome</kwd>
<kwd>epilepsy</kwd>
<kwd>electroencephalography</kwd>
<kwd>autism</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>